Search Results - "Krishnamurthy, Sarath"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2
  3. 3

    THE HIDDEN BURDEN OF EHR-IDENTIFIED FAMILIAL HYPERCHOLESTEROLEMIA: MORTALITY AND CLINICAL OUTCOMES by Patel, Prashant, Kolinovsky, Amy, Ruhl, Jeffrey, Krishnamurthy, Sarath, Beer, Dominik, Kirchner, Lester, Metpally, Raghu, Carey, David, Mehra, Vishal

    “…Methods: In our 1.18 million EHR eligible cohort, International Classification of Disease (ICD)-defined hyperlipidemia was categorized into FH and non FH…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Abstract 2557: Germline mutations in renal cancer predisposing genes: Analysis of the Geisinger MyCode population by Williams, Heinric, Metpally, Raghu, Mohamed, Mahmoud, Krishnamurthy, Sarath, Kip, Sertac, Carey, David J., Baras, Aris, Overton, John

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…Abstract Renal cell cancer (RCC) is not a single disease but is made up of a number of cancers, each with a unique histology, biology, clinical course and…”
    Get full text
    Journal Article
  6. 6

    Abstract 117: Anti-proliferative and cytotoxic effects of verteporfin in endometrial cancer cells by Gogoi, Radhika P., Castañeda-Gill, Jessica M., Metpally, Raghu P., Krishnamurthy, Sarath B., Vishwanatha, Jamboor K., Carey, David J., Nash, John D., Dasari, Venkata Ramesh

    Published in Cancer research (Chicago, Ill.) (01-07-2017)
    “…Abstract Endometrial cancer (EMCA) is the most prevalent gynecologic cancer in women in the United States. The relatively poor prognosis and limited…”
    Get full text
    Journal Article
  7. 7

    Abstract 16505: Sarcomeric Variants in an Imaging-Based, Cardiovascular Phenotype From the Discovehr Cohort by Patel, Prashant, Hu, Yirui, Krishnamurthy, Sarath, Kolinovsky, Amy, Ruhl, Jeffrey, Khan, Ayesha, Kirchner, Lester, Sturm, Amy, Ledbetter, David, Carey, David, Robishaw, Janet, Metpally, Raghu, Mehra, Vishal C

    Published in Circulation (New York, N.Y.) (06-11-2018)
    “…IntroductionThe prevalence of rare (MAF < 1%) nonsynonymous sarcomeric variants in the general population has been estimated at 11% with putative pathogenic…”
    Get full text
    Journal Article